<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Manifestations of hyponatremia and hypernatremia in adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Manifestations of hyponatremia and hypernatremia in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Manifestations of hyponatremia and hypernatremia in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard H Sterns, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Emmett, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John P Forman, MD, MSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 23, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H964230357"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Symptoms of hyponatremia or hypernatremia are primarily neurologic. They are related to the severity and, in particular, the rapidity of the change in the serum sodium concentration [<a href="#rid1">1-3</a>]. Patients with hyponatremia and hypernatremia may also have complaints related to concurrent volume depletion and possible underlying neurologic diseases that predispose to the electrolyte abnormality. These include a wide variety of neurologic disorders that can lead sequentially to either the inappropriate secretion of antidiuretic hormone, water retention, and hyponatremia, or to the lack of expression of thirst, which is normally the major protective mechanism against the development of hypernatremia.</p><p>The cerebral adaptation and clinical manifestations of hyponatremia and hypernatremia will be reviewed here. The etiology and treatment of hyponatremia and hypernatremia are presented elsewhere:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2374.html" rel="external">"Causes of hypotonic hyponatremia in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2350.html" rel="external">"Overview of the treatment of hyponatremia in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2376.html" rel="external">"Etiology and evaluation of hypernatremia in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/2339.html" rel="external">"Treatment of hypernatremia in adults"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">HYPONATREMIA</span><span class="headingEndMark"> — </span>The symptoms directly attributable to hyponatremia primarily occur with acute and marked reductions in the serum sodium concentration and reflect neurologic dysfunction induced by cerebral edema [<a href="#rid1">1,2,4,5</a>], and possibly adaptive responses of brain cells to osmotic swelling [<a href="#rid1">1</a>]. In this setting, the associated fall in serum osmolality creates an osmolal gradient that favors water movement into the cells, leading to brain edema.</p><p>The development of cerebral edema in hyponatremic patients is dependent upon the transfer of water from plasma and cerebrospinal fluid into the brain. Insight into this process is provided by studies in mice without the genes for aquaporin-4, a water channel expressed at the interface between the brain and blood and between the brain and cerebrospinal fluid [<a href="#rid6">6</a>]. Compared with wild-type mice, knockout mice exhibit considerably less brain edema, morbidity, and mortality after the induction of acute hyponatremia, suggesting that aquaporin-4 mediates a substantial portion of osmotic water transport into the brain.</p><p>Hyponatremia-induced cerebral edema occurs primarily with rapid reductions in the serum sodium concentration, usually less than 24 hours [<a href="#rid5">5</a>], as most often occurs in postoperative patients given large quantities of hypotonic fluid and in patients with self-induced water intoxication due to primary polydipsia or exercise-associated hyponatremia. Hypoxic brain injury also may contribute to the neurologic deficit if respiratory arrest has occurred [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/2290.html" rel="external">"Exercise-associated hyponatremia"</a>.)</p><p class="headingAnchor" id="H238335439"><span class="h2">Importance of hypoosmolality in symptom development</span><span class="headingEndMark"> — </span>Hyponatremia is almost always associated with hypoosmolality, and it is the fall in plasma osmolality that promotes the movement of water into the cells and the possible development of cerebral edema. The contribution of hyponatremia itself to the neurologic manifestations is uncertain. This is an important issue, since there are a variety of settings in which hyponatremia is associated with a normal or high measured serum osmolality. These disorders are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/2374.html" rel="external">"Causes of hypotonic hyponatremia in adults"</a>.)</p><p>Summarized briefly:</p><p class="bulletIndent1"><span class="glyph">●</span>In <strong>pseudohyponatremia</strong>, both the serum osmolality and the concentration of sodium in plasma water are normal, and patients are asymptomatic. Such patients have either hyperproteinemia or hyperlipidemia, which reduce the fraction of the plasma that is water from the normal value of 93 percent (the remaining 7 percent is due to proteins and lipids with a small contribution from dissolved solutes) to a lower value that can be less than 80 percent. In such settings, the physiologically important sodium concentration per liter of plasma water is normal, although the sodium concentration per liter of plasma is reduced. The plasma osmolality is normal because osmometers measure the activity of solutes in plasma water.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>With moderate to advanced <strong>kidney function impairment</strong> or with <strong>ethanol intoxication</strong>, hyponatremic patients may have a higher osmolality than that predicted by their sodium concentration due to the contribution of urea or ethanol in the extracellular fluid. However, urea and ethanol are ineffective osmoles since they can freely cross cell membranes and therefore do not obligate water movement out of the cells. Thus, the effective serum osmolality (measured osmolality minus the contribution of urea or ethanol) in such patients is low. As a result, hyponatremic patients with kidney failure or ethanol intoxication are as likely to develop symptoms at a given serum sodium concentration as patients without these conditions. (See  <a class="medical medical_review" href="/z/d/html/2374.html" rel="external">"Causes of hypotonic hyponatremia in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with <strong>uncontrolled diabetes</strong>, the serum osmolality is typically elevated. In contrast to urea, glucose is an effective osmole since it does not freely enter cells. The increase in effective serum osmolality pulls water out of the cells and lowers the serum sodium by dilution, an effect that may be at least partially reversed by the free water loss resulting from the associated glucosuria-induced osmotic diuresis. The neurologic symptoms in these patients are <strong>not</strong> generated by the hyponatremia since the effective plasma osmolality is usually increased rather than reduced. (See  <a class="medical medical_review" href="/z/d/html/1792.html" rel="external">"Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Clinical features, evaluation, and diagnosis", section on 'Serum sodium'</a> and  <a class="medical medical_review" href="/z/d/html/1792.html" rel="external">"Diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults: Clinical features, evaluation, and diagnosis", section on 'Neurologic symptoms'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Isosmotic (or near isosmotic) non-sodium containing, nonconductive <strong>irrigation solutions</strong> containing glycine, <a class="drug drug_general" data-topicid="9587" href="/z/d/drug information/9587.html" rel="external">mannitol</a>, or <a class="drug drug_general" data-topicid="9940" href="/z/d/drug information/9940.html" rel="external">sorbitol</a> may be used during transurethral resection of the prostate or bladder, during hysteroscopy, or laparoscopic surgery. Only a small quantity of this solution is usually absorbed systemically. However, large amounts of the irrigant are occasionally infused by accident into veins or body cavities. Severe hyponatremia due to dilution can result (serum sodium less than 110 mEq/L). Severe neurologic symptoms can occur, but the cause varies, depending upon the irrigant used. Absorption of sorbitol irrigants eventually results in hypotonic hyponatremia as the sorbitol is metabolized. Most glycine irrigants are hypo-osmolar, and absorption of large volumes of the irrigant results in a modest degree of hypotonic hyponatremia; however, in addition to hyponatremia, glycine toxicity and the accumulation of ammonia, serine, and/or glyoxylate from the metabolism of glycine may contribute to neurologic manifestations. (See  <a class="medical medical_review" href="/z/d/html/2363.html" rel="external">"Hyponatremia following transurethral resection, hysteroscopy, or other procedures involving electrolyte-free irrigation", section on 'Pathogenesis of neurologic symptoms'</a>.)</p><p></p><p class="headingAnchor" id="H3"><span class="h2">Clinical manifestations of acute hyponatremia</span><span class="headingEndMark"> — </span>The severity of symptoms in patients with acute hyponatremia generally reflects the severity of cerebral overhydration, which is related to the degree of hyponatremia [<a href="#rid2">2</a>]. The major clinical manifestations of acute hyponatremia include [<a href="#rid1">1,2,7-11</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Nausea and malaise, which are the earliest findings, may be seen when the serum sodium concentration falls below 125 to 130 mEq/L.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Headache, lethargy, obtundation and eventually seizures, coma, and respiratory arrest can occur if the serum sodium concentration falls below 115 to 120 mEq/L. Noncardiogenic pulmonary edema has also been described.</p><p></p><p>Acute hyponatremic encephalopathy may be reversible, but permanent neurologic damage or death can occur, particularly in premenopausal females [<a href="#rid7">7,10</a>]. Overly rapid correction also may be deleterious, particularly in patients with chronic hyponatremia. (See <a class="local">'Susceptibility of premenopausal females'</a> below and <a class="local">'Osmotic demyelination'</a> below.)</p><p class="headingAnchor" id="H4"><span class="h2">Osmolytes and cerebral adaptation to hyponatremia</span><span class="headingEndMark"> — </span>The degree of cerebral edema and therefore the severity of neurologic symptoms are much less with chronic hyponatremia [<a href="#rid2">2,12,13</a>]. This protective response, which begins on the first day and is complete within several days, occurs in two major steps.</p><p class="bulletIndent1"><span class="glyph">●</span>The initial cerebral edema raises the interstitial hydraulic pressure, creating a gradient for extracellular fluid movement out of the brain into the cerebrospinal fluid [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The brain cells then lose solutes, leading to the osmotic movement of water out of the cells and a decrease in brain swelling [<a href="#rid4">4,5,12,14-18</a>]. Brain cell potassium is lost rapidly through normally quiescent cation channels in the cell membrane that are activated by cell swelling. Subsequently, organic solutes (called organic osmolytes) are lost via swelling-activated membrane channels that also transport chloride and other anions [<a href="#rid4">4,15</a>]. Substantial depletion of brain organic osmolytes occurs within 24 hours, and additional losses occur over two to three days owing to downregulation of the synthesis and uptake of these solutes [<a href="#rid4">4,5</a>].</p><p></p><p>These processes are reversed with correction of the hyponatremia [<a href="#rid4">4,5,18</a>]. However, the reuptake of brain solutes during correction occurs more slowly than the loss of brain solutes during the onset of hyponatremia.</p><p>Organic osmolytes account for approximately one-third of the solute loss in chronic hyponatremia  (<a class="graphic graphic_figure graphicRef71152" href="/z/d/graphic/71152.html" rel="external">figure 1</a>) [<a href="#rid17">17</a>]. Reducing the intracellular content of these solutes has the advantage of restoring cell volume without interfering with protein function. By comparison, there would be a potentially deleterious effect on protein function if the volume adaptation were mediated entirely by changes in the cell cation (potassium plus sodium) concentration.</p><p>Studies in hyponatremic animals have shown that the major osmolytes lost from the brain cells are the amino acids glutamine, glutamate, and taurine, and, to a lesser degree, the carbohydrate myoinositol [<a href="#rid5">5,16,17</a>]. A study using proton NMR spectroscopy found a slightly different pattern in humans with chronic hyponatremia; myoinositol and choline compounds were the primary organic solutes lost, with a smaller change occurring in glutamine and glutamate [<a href="#rid18">18</a>]. Myoinositol also appears to be the primary osmolyte taken up by the brain as part of the protective response in patients with hypernatremia. (See <a class="local">'Cerebral adaptation to hypernatremia'</a> below.)</p><p class="headingAnchor" id="H5"><span class="h2">Clinical manifestations of chronic hyponatremia</span><span class="headingEndMark"> — </span>The cerebral adaptation permits patients with chronic hyponatremia to appear to be asymptomatic despite a serum sodium concentration below 120 mmol/L. When symptoms do occur in patients with serum sodium concentrations at this level, they are relatively nonspecific [<a href="#rid1">1,9,19-22</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Fatigue</p><p class="bulletIndent1"><span class="glyph">●</span>Nausea</p><p class="bulletIndent1"><span class="glyph">●</span>Dizziness</p><p class="bulletIndent1"><span class="glyph">●</span>Vomiting</p><p class="bulletIndent1"><span class="glyph">●</span>Gait disturbances</p><p class="bulletIndent1"><span class="glyph">●</span>Forgetfulness</p><p class="bulletIndent1"><span class="glyph">●</span>Confusion</p><p class="bulletIndent1"><span class="glyph">●</span>Lethargy</p><p class="bulletIndent1"><span class="glyph">●</span>Muscle cramps</p><p></p><p>Nausea and vomiting affect approximately one-third of patients with chronic hyponatremia who have a serum sodium concentration &lt;120 mmol/L [<a href="#rid20">20-22</a>]. Nausea and vomiting can be ominous symptoms of life-threatening cerebral edema in patients with acute hyponatremia; by contrast, in chronic hyponatremia, these symptoms are not associated with adverse outcomes. Seizures and coma are uncommon and often reflect an acute exacerbation of the hyponatremia. Symptomatic chronic hyponatremia is rarely, if ever, associated with cerebral edema severe enough to cause herniation of the brain. In a series of 223 patients hospitalized for symptomatic chronic hyponatremia due to thiazide diuretics, there was a 1 percent incidence of seizures and no cases of herniation [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/z/d/html/2288.html" rel="external">"Diuretic-induced hyponatremia"</a>.)</p><p>The older literature includes reports of brain damage in outpatients with thiazide-induced hyponatremia [<a href="#rid8">8</a>]. However, at the time of the study, the consequences of overly rapid correction were unknown. The reported patients were all treated with hypertonic <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a>, increasing the serum sodium concentration by more than 25 mEq/L in 48 hours, a rate of correction that is associated with osmotic demyelination. (See <a class="local">'Osmotic demyelination'</a> below.)</p><p class="headingAnchor" id="H6"><span class="h3">Subtle manifestations in mild to moderate chronic hyponatremia</span><span class="headingEndMark"> — </span>Patients with moderate chronic hyponatremia often appear asymptomatic but may have subtle neurologic manifestations that can easily be missed. These manifestations may be consequences of the brain's adaptations to hyponatremia that make survival possible [<a href="#rid23">23</a>]. The following observations illustrate the range of findings:</p><p class="bulletIndent1"><span class="glyph">●</span>The SALT-1 and SALT-2 trials evaluated the efficacy of the oral vasopressin receptor antagonist <a class="drug drug_general" data-topicid="9512" href="/z/d/drug information/9512.html" rel="external">tolvaptan</a> compared with placebo in patients with chronic hyponatremia; none of the patients had clinically apparent neurologic symptoms at baseline and almost all had a serum sodium concentration of 120 mEq/L or higher [<a href="#rid24">24</a>]. Gradually raising the serum sodium with tolvaptan was associated with significant improvement on the Mental Component of the Medical Outcomes Study Short-Form General Health Survey at 30 days. This benefit was significant only in patients with a serum sodium concentration between 120 and 129 mEq/L and was not seen with correction of mild hyponatremia (130 to 134 mEq/L) or in the placebo group. (See  <a class="medical medical_review" href="/z/d/html/2350.html" rel="external">"Overview of the treatment of hyponatremia in adults", section on 'Vasopressin receptor antagonists'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A case control study found that older adult patients (mean age 72 years) who presented to an emergency department with falls were significantly more likely to have mild to moderate hyponatremia (serum sodium concentration 120 to 130 mEq/L) than older adult patients who did not experience falls [<a href="#rid25">25</a>]. Serial studies in the same patients suggested improvement in gait when the serum sodium concentration was normal.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a case series of 23 older adults with moderate hyponatremia, correction of hyponatremia (usually with urea) improved performance on tests of reaction time and gait; the potential effect was significant among patients older than 65 years but not among younger individuals [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a randomized crossover trial of 14 older adults with moderate hyponatremia (median serum sodium 131 mEq/L), a rise in serum sodium concentration during treatment with a sodium-glucose cotransporter 2 (SGLT2) inhibitor improved scoring on a neurocognitive test (Montreal Cognitive Assessment) [<a href="#rid27">27</a>].</p><p></p><p>Mild to moderate hyponatremia may contribute to fractures in older adult patients [<a href="#rid28">28,29</a>]. In addition to a higher risk of falls, patients with hyponatremia are more likely to have osteoporosis than patients without hyponatremia [<a href="#rid29">29</a>]. The higher prevalence of osteoporosis may be due at least in part to loss of bone sodium. (See  <a class="medical medical_review" href="/z/d/html/2061.html" rel="external">"Osteoporotic fracture risk assessment", section on 'Possible risk factors'</a>.)</p><p>Hyponatremia, even if mild, is associated with increased mortality in both hospitalized and ambulatory patients [<a href="#rid30">30-35</a>]. The reasons for this association have not been identified, but they could reflect some of the adaptations of several organ systems to hyponatremia that allow them to function at low serum sodium concentrations [<a href="#rid23">23</a>]. Mortality risk in hospitalized patients with hyponatremia is increased across virtually all clinical subgroups and persists after hospital discharge, regardless of the underlying disease [<a href="#rid35">35</a>]. A meta-analysis of 15 studies encompassing 13,816 hyponatremic patients found that an improvement in the serum sodium concentration was associated with a decreased mortality rate [<a href="#rid36">36</a>]. This finding likely resulted from simultaneous improvements in underlying comorbidities, rather than a cause-effect relationship between serum sodium and mortality.</p><p>However, the association between serum sodium concentration and mortality in hospitalized patients is nonlinear. Several studies have found that mortality risk increases as serum sodium decreases to approximately 125 mEq/L; below 120 mEq/L, patients have lower rather than higher mortality risk [<a href="#rid37">37-39</a>]. The explanation for this paradox may be that extremely low serum sodium concentrations are most commonly drug induced, whereas mild to moderate hyponatremia is more likely to be associated with a life-threatening underlying disease (malignancy, oliguric kidney failure, heart failure, or hepatic cirrhosis) [<a href="#rid37">37-39</a>]. Similarly, drug-induced hyponatremia tends to resolve spontaneously when the drug is discontinued, while hyponatremia associated with a severe underlying disease tends to persist [<a href="#rid38">38,39</a>].</p><p>Hyponatremia, even if mild, is also associated with increased morbidity in hospitalized patients. As an example, in the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database, the 75,423 patients with preoperative hyponatremia (sodium level of &lt;135 mEq/L) compared with 888,840 patients with normonatremia had significantly higher perioperative 30-day mortality (5.2 versus 1.3 percent), major coronary events (1.8 versus 0.7 percent), wound infection (7.4 versus 4.6 percent), and pneumonia (3.7 versus 1.5 percent) [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H7"><span class="h2">Susceptibility of premenopausal females</span><span class="headingEndMark"> — </span>Premenopausal females and young children with acute postoperative hyponatremia may progress rapidly from minimal symptoms (headache and nausea) to respiratory arrest [<a href="#rid7">7,40</a>]. Cerebral edema and herniation have been found at autopsy, leading some authors to suggest a possible hormonally-mediated decrease in the degree of osmotic adaptation [<a href="#rid7">7,41</a>]. The observation that prepubertal children are at equal risk of symptomatic hyponatremia is compatible with the importance of sex hormones in conferring susceptibility to adult females [<a href="#rid42">42</a>]. Other factors may play a role, such as the size of the brain in relationship to the capacity of the cranial vault, and a more rapid onset of hyponatremia because of smaller body size with less muscle to "buffer" the excess water.</p><p class="headingAnchor" id="H8"><span class="h2">Osmotic demyelination</span><span class="headingEndMark"> — </span>The adaptation that returns the brain volume toward normal in chronic hyponatremia protects against the development of cerebral edema but also creates a potential problem when the serum sodium is therapeutically or spontaneously corrected. In this setting, an overly rapid increase in the serum sodium concentration can lead to an osmotic demyelination syndrome (also called central pontine myelinolysis, although demyelination is often more diffuse and does not necessarily involve the pons). These changes can lead to potentially severe neurologic symptoms that are usually delayed for two to six days after correction and may be irreversible. Thus, patients with symptomatic hyponatremia may initially demonstrate neurologic improvement with correction of the serum sodium but then show late deterioration. This complication of treatment may be reversed by relowering of the serum sodium  (<a class="graphic graphic_figure graphicRef76131" href="/z/d/graphic/76131.html" rel="external">figure 2</a>). These issues are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2317.html" rel="external">"Osmotic demyelination syndrome (ODS) and overly rapid correction of hyponatremia", section on 'Patients who have exceeded correction limits (rescue strategy)'</a> and  <a class="medical medical_review" href="/z/d/html/2317.html" rel="external">"Osmotic demyelination syndrome (ODS) and overly rapid correction of hyponatremia", section on 'Pathogenesis of ODS'</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">HYPERNATREMIA</span><span class="headingEndMark"> — </span>Hypernatremia is basically a mirror image of hyponatremia [<a href="#rid1">1,2,4,5,43</a>]. A rise in the serum sodium concentration and osmolality causes water movement out of the brain.</p><p class="headingAnchor" id="H10"><span class="h2">Manifestations of acute hypernatremia</span><span class="headingEndMark"> — </span>With acute hypernatremia (eg, after the inadvertent infusion of hypertonic <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> into a uterine vein during therapeutic abortion, or the ingestion of large amounts of salt) the rapid decrease in brain volume can cause rupture of the cerebral veins, leading to focal intracerebral and subarachnoid hemorrhages and possibly irreversible neurologic damage [<a href="#rid1">1,2,4,44</a>]. Acute hypernatremia can also result in demyelinating brain lesions similar to those associated with overly rapid correction of chronic hyponatremia [<a href="#rid45">45-50</a>]. (See <a class="local">'Osmotic demyelination'</a> above.)</p><p>The clinical manifestations of acute hypernatremia begin with lethargy, weakness, and irritability, and can progress to twitching, seizures, and coma. Severe symptoms usually require an acute elevation in the serum sodium concentration to above 158 mEq/L. Values above 180 mEq/L are associated with a high mortality rate, particularly in adults [<a href="#rid51">51</a>].</p><p class="headingAnchor" id="H11"><span class="h2">Cerebral adaptation to hypernatremia</span><span class="headingEndMark"> — </span>Beginning on the first day, the initial reduction in brain volume is largely reversed due both to water movement from the cerebrospinal fluid into the brain (thereby increasing the interstitial volume) [<a href="#rid5">5,52</a>] and to the uptake of solutes by the cells (thereby pulling water into the cells and restoring the cell volume) [<a href="#rid5">5,53,54</a>]. The latter response involves an initial uptake of sodium and potassium salts, followed by the later accumulation of osmolytes, which in animals consists primarily of myoinositol, the amino acids glutamine, glutamate, and taurine [<a href="#rid53">53-56</a>]. Myoinositol and taurine are taken up from the extracellular fluid via an increase in the number of sodium-myoinositol and sodium-taurine cotransporters in the cell membrane [<a href="#rid54">54-56</a>]; the source of glutamine and glutamate (uptake from the extracellular fluid or production within the cells) is unknown. The net effect is that these osmolytes, which do not interfere with protein function [<a href="#rid18">18</a>], account for approximately 35 percent of the new cell solute [<a href="#rid54">54</a>].</p><p>A report of an infant with an initial serum sodium concentration of 195 mEq/L confirmed the general applicability of these observations to humans [<a href="#rid57">57</a>]. The patient was first studied using proton NMR spectroscopy on day four when the serum sodium concentration had fallen to 156 mEq/L. At this time, there was a 17 mosmol/kg increase in brain osmolyte concentration, due primarily to the accumulation of myoinositol. The excess brain osmolyte concentration fell to 6 mosmol/kg on day 7 and was normal by day 36.</p><p class="headingAnchor" id="H570048"><span class="h2">Manifestations of chronic hypernatremia</span><span class="headingEndMark"> — </span>As in hyponatremia, the cerebral adaptation in hypernatremia has two important clinical consequences:</p><p class="bulletIndent1"><span class="glyph">●</span>Chronic hypernatremia, which is defined as hypernatremia that has been present for more than a day, is much less likely to induce neurologic symptoms. Assessment of symptoms attributable to hypernatremia is often difficult because most affected adults have underlying neurologic disease. The latter is required to diminish the protective thirst mechanism that normally prevents the development of hypernatremia, even in patients with arginine vasopressin disorders (formerly called diabetes insipidus). (See  <a class="medical medical_review" href="/z/d/html/2376.html" rel="external">"Etiology and evaluation of hypernatremia in adults"</a>.)</p><p></p><p class="bulletIndent1">Like hyponatremia, hypernatremia, even if mild, is associated with increased morbidity and mortality. A cohort study using the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) compared 20,029 patients with preoperative hypernatremia (&gt;144 mmol/L) to 888,840 patients with a normal baseline serum sodium (135 to 144 mmol/L) [<a href="#rid58">58</a>]. Preoperative hypernatremia was associated with increased perioperative 30-day mortality (5.2 versus 1.3 percent), perioperative major coronary events (1.6 versus 0.7 percent), pneumonia (3.4 versus 1.5 percent), and venous thromboembolism (1.8 versus 0.9 percent).</p><p></p><p class="bulletIndent1">In infants, correction of chronic hypernatremia must occur slowly to prevent rapid fluid movement into the brain and cerebral edema, changes that can lead to seizures and coma [<a href="#rid59">59</a>]. Although the brain cells can rapidly lose potassium and sodium in response to cell swelling, the loss of accumulated osmolytes and the water they obligate occurs more slowly [<a href="#rid5">5,54</a>]. The loss of myoinositol, for example, requires both a reduction in the synthesis of new sodium-inositol cotransporters [<a href="#rid55">55</a>] and the activation of a specific inositol efflux mechanism in the cell membrane [<a href="#rid60">60</a>]. The delayed clearance of osmolytes from the cell can predispose to cerebral edema if the serum sodium concentration is lowered too rapidly. As a result, the rate of correction in young children with hypernatremia should be less than 10 to 12 mEq/L per day [<a href="#rid61">61,62</a>]. </p><p></p><p class="bulletIndent1">Rapid correction of hypernatremia has not been shown to have adverse consequences in adults [<a href="#rid63">63-65</a>], and fear of cerebral edema from overly rapid correction of hypernatremia, which has only been reported in infants, should not deter vigorous rehydration of adults with acute hypernatremia who are at risk of developing osmotic demyelination or brain hemorrhage from untreated hypernatremia. Unlike hyponatremia, there is little risk of inadvertent overcorrection in adults with hypernatremia; such patients are often undertreated, and more rapid correction may be beneficial [<a href="#rid1">1,66,67</a>]. As an example, in a retrospective study of 4265 adults with serum sodium concentrations ≥155 mEq/L (most had chronic hypernatremia), patients corrected by &gt;0.5 mEq/L per hour had decreased 30-day mortality compared with those corrected more slowly [<a href="#rid65">65</a>]. Although it is difficult to exclude confounding by comorbidities, there was no evidence of harm from more rapid correction. These findings support vigorous rehydration of adults with hypernatremia regardless of the duration of the disturbance. (See  <a class="medical medical_review" href="/z/d/html/2339.html" rel="external">"Treatment of hypernatremia in adults", section on 'Choosing a rate of correction'</a>.)</p><p></p><p class="headingAnchor" id="H12"><span class="h1">SENSING OF CHANGES IN PLASMA OSMOLALITY</span><span class="headingEndMark"> — </span>Although the mechanisms of protective solute loss in hyponatremia and solute uptake in hypernatremia have been largely defined, the mechanisms by which the alterations in plasma osmolality are sensed by the cells (particularly brain cells) and then lead to the physiologically appropriate changes in solute content are not well understood. There is preliminary evidence that hyperosmolality, perhaps via stress on the cytoskeleton as the cell volume falls, activates a specific protein kinase [<a href="#rid68">68</a>]. This kinase, via protein phosphorylation, may then lead to activation of transporters, such as the sodium-inositol cotransporter, that promote solute uptake into the cells.</p><p class="headingAnchor" id="H117803785"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/109682.html" rel="external">"Society guideline links: Hyponatremia"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/109733.html" rel="external">"Society guideline links: Fluid and electrolyte disorders in adults"</a>.)</p><p class="headingAnchor" id="H109594005"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/16938.html" rel="external">"Patient education: Hyponatremia (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H13"><span class="h1">SUMMARY</span><span class="headingEndMark"> — </span>Symptoms associated with hyponatremia or hypernatremia are primarily neurologic and related to the severity and rapidity of the change in the serum sodium concentration. Such symptoms must be distinguished from those of concurrent volume depletion and possible underlying neurologic diseases that may predispose to the electrolyte abnormality. (See <a class="local">'Introduction'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hyponatremia: Clinical manifestations</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Symptoms directly attributable to hyponatremia reflect neurologic dysfunction induced by cerebral edema. Cerebral edema is due to a decrease in serum osmolality which causes water movement into cells.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Clinical manifestations of acute hyponatremia reflect the severity of cerebral overhydration. Nausea and malaise are the earliest findings, and may be seen at a serum sodium concentration below 125 to 130 mEq/L. Headache, lethargy, obtundation and eventually seizures, coma, and respiratory arrest may occur if the serum sodium concentration falls below 115 to 120 mEq/L. Hyponatremic encephalopathy may be reversible or permanent. Premenopausal females appear to be at greater risk for severe hyponatremic symptoms and for residual neurologic injury. (See <a class="local">'Clinical manifestations of acute hyponatremia'</a> above and <a class="local">'Susceptibility of premenopausal females'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Because of the cerebral adaptation, neurologic symptoms are much less severe with chronic hyponatremia. Patients with chronic hyponatremia may appear to be asymptomatic despite a serum sodium concentration that is persistently below 120 mEq/L. Symptoms that do occur include fatigue, nausea, dizziness, gait disturbances, forgetfulness, confusion, lethargy, and muscle cramps. Seizures and coma are uncommon and often reflect an acute exacerbation of the hyponatremia. (See <a class="local">'Osmolytes and cerebral adaptation to hyponatremia'</a> above and <a class="local">'Clinical manifestations of chronic hyponatremia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Neurologic manifestations resulting from chronic hyponatremia, including gait disturbance and attention deficits, may result in increased falls among older adult patients. Even mild hyponatremia is associated with increased mortality, although the hyponatremia may just be a marker for more severe underlying disease. (See <a class="local">'Subtle manifestations in mild to moderate chronic hyponatremia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An overly rapid increase in the serum sodium concentration can lead to osmotic demyelination syndrome (also called central pontine myelinolysis) resulting in severe and potentially irreversible neurologic symptoms. (See <a class="local">'Osmotic demyelination'</a> above and  <a class="medical medical_review" href="/z/d/html/2317.html" rel="external">"Osmotic demyelination syndrome (ODS) and overly rapid correction of hyponatremia", section on 'Pathogenesis of ODS'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypernatremia: Clinical manifestations</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hypernatremia causes water movement out of the brain resulting in a decrease in brain volume that, if acute, can cause focal intracerebral and subarachnoid hemorrhages, demyelinating brain lesions, and irreversible neurologic damage. (See <a class="local">'Manifestations of acute hypernatremia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hypernatremic patients who become symptomatic present with lethargy, weakness, and irritability, and may develop twitching, seizures, and coma. Severe symptoms usually require an acute elevation in the serum sodium concentration to above 158 mEq/L. Values above 180 mEq/L are associated with a high mortality rate, particularly in adults. (See <a class="local">'Manifestations of acute hypernatremia'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Because of the cerebral adaptation, chronic hypernatremia is less likely to induce neurologic symptoms. The correction of chronic hypernatremia must occur slowly to prevent rapid fluid movement into the brain and cerebral edema. The rate of correction in asymptomatic patients should not exceed 12 mEq/L per day, which represents an average of 0.5 mEq/L per hour. (See <a class="local">'Cerebral adaptation to hypernatremia'</a> above and  <a class="medical medical_review" href="/z/d/html/2339.html" rel="external">"Treatment of hypernatremia in adults", section on 'Choosing a rate of correction'</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Sterns RH. Disorders of plasma sodium--causes, consequences, and correction. N Engl J Med 2015; 372:55.</a></li><li class="breakAll">Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed, McGraw-Hill, New York 2001. p.716, 761.</li><li><a class="nounderline abstract_t">Yeates KE, Singer M, Morton AR. Salt and water: a simple approach to hyponatremia. CMAJ 2004; 170:365.</a></li><li><a class="nounderline abstract_t">McManus ML, Churchwell KB, Strange K. Regulation of cell volume in health and disease. N Engl J Med 1995; 333:1260.</a></li><li><a class="nounderline abstract_t">Strange K. Regulation of solute and water balance and cell volume in the central nervous system. J Am Soc Nephrol 1992; 3:12.</a></li><li><a class="nounderline abstract_t">Manley GT, Fujimura M, Ma T, et al. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000; 6:159.</a></li><li><a class="nounderline abstract_t">Ayus JC, Wheeler JM, Arieff AI. Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med 1992; 117:891.</a></li><li><a class="nounderline abstract_t">Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 1981; 70:1163.</a></li><li><a class="nounderline abstract_t">Ellis SJ. Severe hyponatraemia: complications and treatment. QJM 1995; 88:905.</a></li><li><a class="nounderline abstract_t">Moritz ML, Ayus JC. The pathophysiology and treatment of hyponatraemic encephalopathy: an update. Nephrol Dial Transplant 2003; 18:2486.</a></li><li><a class="nounderline abstract_t">Ayus JC, Varon J, Arieff AI. Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med 2000; 132:711.</a></li><li><a class="nounderline abstract_t">Laureno R, Karp BI. Myelinolysis after correction of hyponatremia. Ann Intern Med 1997; 126:57.</a></li><li><a class="nounderline abstract_t">Sterns RH, Thomas DJ, Herndon RM. Brain dehydration and neurologic deterioration after rapid correction of hyponatremia. Kidney Int 1989; 35:69.</a></li><li><a class="nounderline abstract_t">Melton JE, Patlak CS, Pettigrew KD, Cserr HF. Volume regulatory loss of Na, Cl, and K from rat brain during acute hyponatremia. Am J Physiol 1987; 252:F661.</a></li><li><a class="nounderline abstract_t">Strange K, Jackson PS. Swelling-activated organic osmolyte efflux: a new role for anion channels. Kidney Int 1995; 48:994.</a></li><li><a class="nounderline abstract_t">Lien YH, Shapiro JI, Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 1991; 88:303.</a></li><li><a class="nounderline abstract_t">Verbalis JG, Gullans SR. Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats. Brain Res 1991; 567:274.</a></li><li><a class="nounderline abstract_t">Videen JS, Michaelis T, Pinto P, Ross BD. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. J Clin Invest 1995; 95:788.</a></li><li><a class="nounderline abstract_t">Sterns RH, Cappuccio JD, Silver SM, Cohen EP. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol 1994; 4:1522.</a></li><li><a class="nounderline abstract_t">Chow KM, Kwan BC, Szeto CC. Clinical studies of thiazide-induced hyponatremia. J Natl Med Assoc 2004; 96:1305.</a></li><li><a class="nounderline abstract_t">Nigro N, Winzeler B, Suter-Widmer I, et al. Symptoms and characteristics of individuals with profound hyponatremia: a prospective multicenter observational study. J Am Geriatr Soc 2015; 63:470.</a></li><li><a class="nounderline abstract_t">Arampatzis S, Frauchiger B, Fiedler GM, et al. Characteristics, symptoms, and outcome of severe dysnatremias present on hospital admission. Am J Med 2012; 125:1125.e1.</a></li><li><a class="nounderline abstract_t">Portales-Castillo I, Sterns RH. Allostasis and the Clinical Manifestations of Mild to Moderate Chronic Hyponatremia: No Good Adaptation Goes Unpunished. Am J Kidney Dis 2019; 73:391.</a></li><li><a class="nounderline abstract_t">Schrier RW, Gross P, Gheorghiade M, et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006; 355:2099.</a></li><li><a class="nounderline abstract_t">Renneboog B, Musch W, Vandemergel X, et al. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006; 119:71.e1.</a></li><li><a class="nounderline abstract_t">Renneboog B, Sattar L, Decaux G. Attention and postural balance are much more affected in older than in younger adults with mild or moderate chronic hyponatremia. Eur J Intern Med 2017; 41:e25.</a></li><li><a class="nounderline abstract_t">Refardt J, Imber C, Nobbenhuis R, et al. Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. J Am Soc Nephrol 2023; 34:322.</a></li><li><a class="nounderline abstract_t">Gankam Kengne F, Andres C, Sattar L, et al. Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 2008; 101:583.</a></li><li><a class="nounderline abstract_t">Verbalis JG, Barsony J, Sugimura Y, et al. Hyponatremia-induced osteoporosis. J Bone Miner Res 2010; 25:554.</a></li><li><a class="nounderline abstract_t">Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia. Am J Med 2009; 122:857.</a></li><li><a class="nounderline abstract_t">Wald R, Jaber BL, Price LL, et al. Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 2010; 170:294.</a></li><li><a class="nounderline abstract_t">Doshi SM, Shah P, Lei X, et al. Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. Am J Kidney Dis 2012; 59:222.</a></li><li><a class="nounderline abstract_t">Leung AA, McAlister FA, Rogers SO Jr, et al. Preoperative hyponatremia and perioperative complications. Arch Intern Med 2012; 172:1474.</a></li><li><a class="nounderline abstract_t">Gankam-Kengne F, Ayers C, Khera A, et al. Mild hyponatremia is associated with an increased risk of death in an ambulatory setting. Kidney Int 2013; 83:700.</a></li><li><a class="nounderline abstract_t">Holland-Bill L, Christiansen CF, Heide-Jørgensen U, et al. Hyponatremia and mortality risk: a Danish cohort study of 279 508 acutely hospitalized patients. Eur J Endocrinol 2015; 173:71.</a></li><li><a class="nounderline abstract_t">Corona G, Giuliani C, Verbalis JG, et al. Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis. PLoS One 2015; 10:e0124105.</a></li><li><a class="nounderline abstract_t">Chawla A, Sterns RH, Nigwekar SU, Cappuccio JD. Mortality and serum sodium: do patients die from or with hyponatremia? Clin J Am Soc Nephrol 2011; 6:960.</a></li><li><a class="nounderline abstract_t">Winzeler B, Jeanloz N, Nigro N, et al. Long-term outcome of profound hyponatremia: a prospective 12 months follow-up study. Eur J Endocrinol 2016; 175:499.</a></li><li><a class="nounderline abstract_t">Krummel T, Prinz E, Metten MA, et al. Prognosis of patients with severe hyponatraemia is related not only to hyponatraemia but also to comorbidities and to medical management: results of an observational retrospective study. BMC Nephrol 2016; 17:159.</a></li><li><a class="nounderline abstract_t">Arieff AI. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. N Engl J Med 1986; 314:1529.</a></li><li><a class="nounderline abstract_t">Fraser CL, Kucharczyk J, Arieff AI, et al. Sex differences result in increased morbidity from hyponatremia in female rats. Am J Physiol 1989; 256:R880.</a></li><li><a class="nounderline abstract_t">Arieff AI, Ayus JC, Fraser CL. Hyponatraemia and death or permanent brain damage in healthy children. BMJ 1992; 304:1218.</a></li><li><a class="nounderline abstract_t">Adrogué HJ, Madias NE. Hypernatremia. N Engl J Med 2000; 342:1493.</a></li><li><a class="nounderline abstract_t">Furukawa S, Takaya A, Nakagawa T, et al. Fatal hypernatremia due to drinking a large quantity of shoyu (Japanese soy sauce). J Forensic Leg Med 2011; 18:91.</a></li><li><a class="nounderline abstract_t">Soupart A, Penninckx R, Namias B, et al. Brain myelinolysis following hypernatremia in rats. J Neuropathol Exp Neurol 1996; 55:106.</a></li><li><a class="nounderline abstract_t">Brown WD, Caruso JM. Extrapontine myelinolysis with involvement of the hippocampus in three children with severe hypernatremia. J Child Neurol 1999; 14:428.</a></li><li><a class="nounderline abstract_t">Chang L, Harrington DW, Milkotic A, et al. Unusual occurrence of extrapontine myelinolysis associated with acute severe hypernatraemia caused by central diabetes insipidus. Clin Endocrinol (Oxf) 2005; 63:233.</a></li><li><a class="nounderline abstract_t">Odier C, Nguyen DK, Panisset M. Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis. J Neurol 2010; 257:1176.</a></li><li><a class="nounderline abstract_t">van der Helm-van Mil AH, van Vugt JP, Lammers GJ, Harinck HI. Hypernatremia from a hunger strike as a cause of osmotic myelinolysis. Neurology 2005; 64:574.</a></li><li><a class="nounderline abstract_t">Ismail FY, Szóllics A, Szólics M, et al. Clinical semiology and neuroradiologic correlates of acute hypernatremic osmotic challenge in adults: a literature review. AJNR Am J Neuroradiol 2013; 34:2225.</a></li><li><a class="nounderline abstract_t">Moder KG, Hurley DL. Fatal hypernatremia from exogenous salt intake: report of a case and review of the literature. Mayo Clin Proc 1990; 65:1587.</a></li><li><a class="nounderline abstract_t">Pullen RG, DePasquale M, Cserr HF. Bulk flow of cerebrospinal fluid into brain in response to acute hyperosmolality. Am J Physiol 1987; 253:F538.</a></li><li><a class="nounderline abstract_t">Heilig CW, Stromski ME, Blumenfeld JD, et al. Characterization of the major brain osmolytes that accumulate in salt-loaded rats. Am J Physiol 1989; 257:F1108.</a></li><li><a class="nounderline abstract_t">Lien YH, Shapiro JI, Chan L. Effects of hypernatremia on organic brain osmoles. J Clin Invest 1990; 85:1427.</a></li><li><a class="nounderline abstract_t">Paredes A, McManus M, Kwon HM, Strange K. Osmoregulation of Na(+)-inositol cotransporter activity and mRNA levels in brain glial cells. Am J Physiol 1992; 263:C1282.</a></li><li><a class="nounderline abstract_t">De Petris L, Luchetti A, Emma F. Cell volume regulation and transport mechanisms across the blood-brain barrier: implications for the management of hypernatraemic states. Eur J Pediatr 2001; 160:71.</a></li><li><a class="nounderline abstract_t">Lee JH, Arcinue E, Ross BD. Brief report: organic osmolytes in the brain of an infant with hypernatremia. N Engl J Med 1994; 331:439.</a></li><li><a class="nounderline abstract_t">Leung AA, McAlister FA, Finlayson SR, Bates DW. Preoperative hypernatremia predicts increased perioperative morbidity and mortality. Am J Med 2013; 126:877.</a></li><li><a class="nounderline abstract_t">Hogan GR, Dodge PR, Gill SR, et al. Pathogenesis of seizures occurring during restoration of plasma tonicity to normal in animals previously chronically hypernatremic. Pediatrics 1969; 43:54.</a></li><li><a class="nounderline abstract_t">Strange K, Morrison R, Shrode L, Putnam R. Mechanism and regulation of swelling-activated inositol efflux in brain glial cells. Am J Physiol 1993; 265:C244.</a></li><li><a class="nounderline abstract_t">Fang C, Mao J, Dai Y, et al. Fluid management of hypernatraemic dehydration to prevent cerebral oedema: a retrospective case control study of 97 children in China. J Paediatr Child Health 2010; 46:301.</a></li><li><a class="nounderline abstract_t">Bolat F, Oflaz MB, Güven AS, et al. What is the safe approach for neonatal hypernatremic dehydration? A retrospective study from a neonatal intensive care unit. Pediatr Emerg Care 2013; 29:808.</a></li><li><a class="nounderline abstract_t">Chauhan K, Pattharanitima P, Patel N, et al. Rate of Correction of Hypernatremia and Health Outcomes in Critically Ill Patients. Clin J Am Soc Nephrol 2019; 14:656.</a></li><li><a class="nounderline abstract_t">Sterns RH. Evidence for Managing Hypernatremia: Is It Just Hyponatremia in Reverse? Clin J Am Soc Nephrol 2019; 14:645.</a></li><li><a class="nounderline abstract_t">Feigin E, Feigin L, Ingbir M, et al. Rate of Correction and All-Cause Mortality in Patients With Severe Hypernatremia. JAMA Netw Open 2023; 6:e2335415.</a></li><li><a class="nounderline abstract_t">Bataille S, Baralla C, Torro D, et al. Undercorrection of hypernatremia is frequent and associated with mortality. BMC Nephrol 2014; 15:37.</a></li><li><a class="nounderline abstract_t">Alshayeb HM, Showkat A, Babar F, et al. Severe hypernatremia correction rate and mortality in hospitalized patients. Am J Med Sci 2011; 341:356.</a></li><li><a class="nounderline abstract_t">Galcheva-Gargova Z, Dérijard B, Wu IH, Davis RJ. An osmosensing signal transduction pathway in mammalian cells. Science 1994; 265:806.</a></li></ol></div><div id="topicVersionRevision">Topic 2287 Version 21.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25551526" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Disorders of plasma sodium--causes, consequences, and correction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25551526" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Disorders of plasma sodium--causes, consequences, and correction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14757675" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Salt and water: a simple approach to hyponatremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7566004" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Regulation of cell volume in health and disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1391705" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Regulation of solute and water balance and cell volume in the central nervous system.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10655103" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1443949" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Postoperative hyponatremic encephalopathy in menstruant women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7234886" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8593551" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Severe hyponatraemia: complications and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14605269" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The pathophysiology and treatment of hyponatraemic encephalopathy: an update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10787364" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8992924" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Myelinolysis after correction of hyponatremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2709662" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Brain dehydration and neurologic deterioration after rapid correction of hyponatremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3565577" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Volume regulatory loss of Na, Cl, and K from rat brain during acute hyponatremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8569109" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Swelling-activated organic osmolyte efflux: a new role for anion channels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2056123" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1817731" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Hyponatremia causes large sustained reductions in brain content of multiple organic osmolytes in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7860762" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8025225" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15540881" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Clinical studies of thiazide-induced hyponatremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25735607" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Symptoms and characteristics of individuals with profound hyponatremia: a prospective multicenter observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22939097" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Characteristics, symptoms, and outcome of severe dysnatremias present on hospital admission.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30554800" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Allostasis and the Clinical Manifestations of Mild to Moderate Chronic Hyponatremia: No Good Adaptation Goes Unpunished.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17105757" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16431193" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28215977" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Attention and postural balance are much more affected in older than in younger adults with mild or moderate chronic hyponatremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36396331" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18477645" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Mild hyponatremia and risk of fracture in the ambulatory elderly.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19751154" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Hyponatremia-induced osteoporosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19699382" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Mortality after hospitalization with mild, moderate, and severe hyponatremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20142578" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Impact of hospital-associated hyponatremia on selected outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22001181" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22965221" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Preoperative hyponatremia and perioperative complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23325088" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Mild hyponatremia is associated with an increased risk of death in an ambulatory setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26036812" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Hyponatremia and mortality risk: a Danish cohort study of 279 508 acutely hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25905459" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21441132" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Mortality and serum sodium: do patients die from or with hyponatremia?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27585594" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Long-term outcome of profound hyponatremia: a prospective 12 months follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27770791" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Prognosis of patients with severe hyponatraemia is related not only to hyponatraemia but also to comorbidities and to medical management: results of an observational retrospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3713746" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2539758" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Sex differences result in increased morbidity from hyponatremia in female rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1515791" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Hyponatraemia and death or permanent brain damage in healthy children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10816188" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Hypernatremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21315305" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Fatal hypernatremia due to drinking a large quantity of shoyu (Japanese soy sauce).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8558165" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Brain myelinolysis following hypernatremia in rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10573464" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Extrapontine myelinolysis with involvement of the hippocampus in three children with severe hypernatremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16060921" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Unusual occurrence of extrapontine myelinolysis associated with acute severe hypernatraemia caused by central diabetes insipidus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20148334" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15699405" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Hypernatremia from a hunger strike as a cause of osmotic myelinolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23413245" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Clinical semiology and neuroradiologic correlates of acute hypernatremic osmotic challenge in adults: a literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2255221" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Fatal hypernatremia from exogenous salt intake: report of a case and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3115117" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Bulk flow of cerebrospinal fluid into brain in response to acute hyperosmolality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2603957" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Characterization of the major brain osmolytes that accumulate in salt-loaded rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2332498" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Effects of hypernatremia on organic brain osmoles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1476169" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Osmoregulation of Na(+)-inositol cotransporter activity and mRNA levels in brain glial cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11271393" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Cell volume regulation and transport mechanisms across the blood-brain barrier: implications for the management of hypernatraemic states.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8035840" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Brief report: organic osmolytes in the brain of an infant with hypernatremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23910520" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Preoperative hypernatremia predicts increased perioperative morbidity and mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5764069" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Pathogenesis of seizures occurring during restoration of plasma tonicity to normal in animals previously chronically hypernatremic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8393281" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Mechanism and regulation of swelling-activated inositol efflux in brain glial cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20412412" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Fluid management of hypernatraemic dehydration to prevent cerebral oedema: a retrospective case control study of 97 children in China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23823259" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : What is the safe approach for neonatal hypernatremic dehydration? A retrospective study from a neonatal intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30948456" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Rate of Correction of Hypernatremia and Health Outcomes in Critically Ill Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31064771" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Evidence for Managing Hypernatremia: Is It Just Hyponatremia in Reverse?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37768662" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Rate of Correction and All-Cause Mortality in Patients With Severe Hypernatremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24559470" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Undercorrection of hypernatremia is frequent and associated with mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21358313" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Severe hypernatremia correction rate and mortality in hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8047888" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : An osmosensing signal transduction pathway in mammalian cells.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
